期刊文献+

支气管哮喘联合用药研究进展 被引量:38

暂未订购
导出
摘要 支气管哮喘发病有多种因素参与,可以针对不同因素采用联合治疗。联合吸入ICS和LABA,对控制哮喘气道炎症和改善气道平滑肌功能具有一定的协同作用和互补效果,常用的三种联合制剂沙美特罗/丙酸氟替卡松、布地奈德/福莫特罗、丙酸倍氯米松/福莫特罗通过各自不同的药物特点和装置发挥作用;白三烯受体拮抗剂通过减少白三烯的释放,与ICS和LABA联合起到互补协同效应;ICS还可以和长效茶碱、抗过敏药物以及免疫调节剂等合理地联合应用,以增加疗效,达到并维持哮喘控制。
出处 《安徽医药》 CAS 2010年第4期473-475,共3页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献23

  • 1儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753. 被引量:2546
  • 2Johnson M. Interactions between Corticosteroids and β2-Agonistsin in Asthma and Chronic Obstructive Pulmonary Disease[ J]. Proc Am Thorac Soc,2004,1:200 - 6.
  • 3Mark L Levya, Mike Thomasb, Iain R Smallc, et al. Summary of the 2008 BTS/SIGN British Guideline on the Management of Asthma [ J ]. Primary Care Respiratory Journal,2009,18, Suppl 1 : S1-16.
  • 4Manminder Kaur, Neit S. Holden, Sylvia M. Wilson, et al. Effect of β2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells : a role for protein kinase A [ J ]. Am J Physiol Lung Cell Mol Physiol, 2008,295 : 505 -5.
  • 5Mark Salter, Keith Biggadike ,Joyce E. Matthews, et al. Pharmacological properties of the enhanced-affinity gtucocorticoid fluticasone furoate in vitro and in vivo model of respiratory inflammatory disease [ J]. Am J Physiol Lung Cell Mol Physiol,2007 ,293 :660 -7.
  • 6Manminder Kaur, Joanna E. Chivers, Mark A. Giembycz,et al. Long- Acting β2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells [ J ]. Molecular Pharmacology, 2008,73 ( 1 ) :203 -14.
  • 7Karl-Christian Bergmanna, L. Lindemannb, R. Braunc, et al. Salmet- erol/flutieasone propionate(50/250 nag) combination is superior to double dose fluticasone (500 mg) for the treatment of symptomatic moderate asthma[ J]. Swiss reed Wkly,2004,134:50-8.
  • 8Rajeswari Singam, Prasanna K Jena, Sumita Behera, et al. Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice [ J ]. Virology Journal ,2006,3:32.
  • 9周敏,倪谨华,郑丽叶,黄绍光,万欢英,邓伟吾.信必可都保对持续性哮喘的疗效观察[J].上海第二医科大学学报,2005,25(1):74-76. 被引量:2
  • 10Klaus F. Rabe, Emilio Pizzichini, Bjorn Stallberg, et al. Budesonide/ Fonnoterol in a Single Inhaler for Maintenance and Relief in Mild- to-Moderate Asthma[ J ]. Chest ,2006,129:246 - 6.

二级参考文献43

  • 1陈妙,雷后兴,吴静,黄刘炜,蓝菊红.哮喘患儿血IL-4及Eotaxin的含量变化及意义[J].中国全科医学,2004,7(12):867-868. 被引量:13
  • 2陈丽娟.支气管哮喘药物治疗进展[J].中国全科医学,2006,9(6):486-487. 被引量:30
  • 3徐治波,冯玉麟.变应性鼻炎、支气管哮喘——同一气道,同一种病[J].实用医院临床杂志,2006,3(6):10-11. 被引量:12
  • 4齐静姣,张平,任新乐.哮喘患儿血清可溶性细胞间黏附分子-1水平的检测研究[J].中国现代医学杂志,2007,17(2):180-182. 被引量:7
  • 5胡仪吉.反复呼吸道感染的诊断标准[J].中华儿科杂志,1988,26(1):41-41.
  • 6Bateman ED, Bantje TA, Joao GM, et al. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma[J]. Am J Respir Med, 2003, 2:275 -281.
  • 7Lalloo UG, Malolepszy J, Kozma D, et al. Budesonide and formoterol in a singer inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma[ J]. Chest, 2003, 123 : 1480 - 1487.
  • 8National Heart, Lung and Blood Institutes. Workshop report:global strategy for asthma management and prevention [ M ]. New York:WHO/NHLBI. 2002.12 - 16.
  • 9Baraniuk JN, Ali M, Brody D, et al. Glucocorticoid induce β 2-adrenergic receptor function in human nasal mucosa [ J ]. Am J Respir Med, 1997, 155:704-710.
  • 10Eickelberg U, Roth M, Lorx R, et al. Ligand-independent activation of the glucocorticoid receptor by β2-arenergic rceptor aonists in primary human lung fibroblasts and vascular smooth mucle cells [ J ].J Bio Chem, 1999, 274:1005 - 1010.

共引文献2572

同被引文献276

二级引证文献361

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部